Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres

Gene Therapy

Volumn 6, Issue 8, 1999, Pages 1406-1414

  Baranov, A ^a   Glazkov, P ^a   Kiselev, A ^a   Ostapenko, O ^a   Mikhailov, V ^b   Ivaschenko, T ^a   Sabetsky, V ^c   Baranov, V S ^a  

^a D O OTT RESEARCH INSTITUTE OF OBSTETRICS   (Russian Federation)

^b INSTITUTE OF CYTOLOGY   (Russian Federation)

^c Biosystem XXI Ltd   (Russian Federation)

Author keywords

Distant transfection; Duchenne muscular dystrophy; Dystrophin; Gene transfer; Synthetic microspheres

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; DYSTROPHIN; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE TARGETING; MOUSE; MUSCLE CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

ANIMALS; BETA-GALACTOSIDASE; DNA, COMPLEMENTARY; DYSTROPHIN; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INJECTIONS, INTRAMUSCULAR; LAC OPERON; MICE; MICE, INBRED MDX; MICROSPHERES; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; TRANSFECTION;

EID: 0032841235     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300954     Document Type: Article

References (22)

1. Emery AEH. Duchenne Muscular Dystrophy, 2nd edn. Oxford Monograph on Medical Genetics, 24. Oxford University Press: Oxford, 1993, p157.
2. Partridge TA. Models of dystrophinopathy, pathological mechanisms and assessment of therapies. In: Brown SC, Lucy JA (eds). Dystrophin: Gene, Protein and Cell Biology. Cambridge University Press: Cambridge, 1997, pp 310-331.
3. Engel AG, Yamamoto M, Fischbeck KH. Dystrophinopathies. In: Engel AG, Franzini-Armstrong C (eds). Myology. McGraw-Hill: New York, 1994, pp 1133-1187.
4. Clemens PR et al. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Therapy 1996; 3: 965-972.
5. Lochmuller H et al. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Therapy 1996; 3: 706-716.
6. Fassati A, Murphy S, Dickson G. Gene therapy of Duchenne muscular dystrophy. Adv Genet 1997; 35: 117-153.
7. Budker V et al. The efficient expression of intravascularly delivered DNA in rat muscles. Gene Therapy 1998; 5: 272-276.
8. Dodds E et al. Lipofection of cultured mouse muscle cells: a direct comparison of Lipofectamine and DOSPER. Gene Therapy 1998; 5: 542-551.
9. Vitiello L et al. Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. Gene Therapy 1996; 3: 396-404.
10. Baranov V et al. Human dystrophin gene expression in mdx muscles after in vivo ballistic transfection, application of synthetic oligopeptide complexes and cationic liposomes. In: NATO ASI, Subseries M, 1997, 105: 219-223.
11. Zelenin V, Tarasenko O, Kolesnikov VA et al. Bacterial β-galactosidase and human dystrophin genes are expressed in mouse skeletal muscle fibers after ballistic transfection. FEBS Lett 1997; 414: 319-322.
12. Mathiowitz E, Jacob JS, Jong YS et al. Biologically erodable microspheres as potential oral drug delivery system. Nature 1997; 386: 410-414.
13. Walsh S et al. Simultaneous delivery of drugs and genes by gelatin nanospheres. Pediatric Pulmonology 1997; (Suppl. 14) 255-257.
14. Bockhold KJ, Rosenblatt JD, Partridge TA. Aging normal and dystrophic muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve 1998; 21: 173-183.
15. Feero WG et al. Selection and use of ligands for receptor-mediated gene delivery to myogenic cells. Gene Therapy 1997; 4: 664-674.
16. Cox GA et al. Overexpression of dystrophin in transgenic mdx mice eliminated dystrophic symptoms without toxicity. Nature 1993; 364: 725-729.
17. Yanagihara I et al. Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection. Gene Therapy 1996; 3: 549-553.
18. Skarli M et al. Myosin regulatory elements as vector for gene transfer by intramuscular injection. Gene Therapy 1998; 5: 514-520.
19. Liu F, Qi H, Huang L, Liu D. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Therapy 1997; 4: 517-523.
20. Coonrod A, Li F-Q, Horwitz M. On the mechanism of DNA transfection: efficient gene transfer without viruses. Gene Therapy 1997; 4: 1313-1321.
21. Wells D, Wells K, Asante EA et al. Expression of human full length and mini-dystrophin in transgenic mdx mice: implication for gene therapy of Duchenne muscular dystrophy. Hum Mol Genet 1995; 3: 1245-1250.
22. Roberts RG, Barby TFM, Manner E et al. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet 1991; 49: 298-310.